Outgoing FDA Commissioner raises concerns about safety of online-purchased compounded weight loss meds, highlighting challenges faced by the FDA, amidst contrasting views from nominee for Health and Human Services Secretary.
Novo Nordisk's high-dose semaglutide trial demonstrates a 20.7% weight reduction in overweight patients with obesity, promising new advancements in the treatment of obesity and diabetes.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
This study explores the role of waist circumference, body mass index, and high-sensitivity C-reactive protein in pediatric steatotic liver disease, identifying waist circumference as a significant non-invasive screening tool.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A recent study reveals, 'Higher body size in adulthood increased the risk of later-life anxiety and depression, independent of childhood body size,' highlighting the critical role of managing adult obesity to mitigate mental health risks.
The FDA has proposed a new front-of-package nutrition label for packaged foods, in line with broader efforts to address the nation's chronic disease crisis. The World Health Organization has also advocated for easily accessible nutritional information to support healthier choices.
Significant gender disparities in the GC incidence exist with higher incidence and mortality rates noted in men compared to women across different age groups.